Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 6424
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 37nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 47nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 56nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 63nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 79nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 118nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 345nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 583nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 4.30E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 7.80E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 8.70E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 1.45E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 1.78E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Washington University; Sage Therapeutics, Inc.
US Patent
Washington University; Sage Therapeutics, Inc.
US Patent
Affinity DataIC50: 3.00E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair













